Apoptosis and disease: Regulation and clinical relevance of programmed cell death

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 267-281

  Rudin, Charles M ^a   Thompson, Craig B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bcl 2; Homeostasis; Inhibitor of apoptosis; Interleukin 1 converting enzymes; Tumor necrosis factor receptors

Indexed keywords

INTERLEUKIN 1BETA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; AUTOIMMUNITY; CANCER; CELL DEATH; CELL PROLIFERATION; DEGENERATIVE DISEASE; ETIOLOGY; GENE MUTATION; HOMEOSTASIS; INFECTION; MOLECULAR MIMICRY; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 1; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0031046848     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.267     Document Type: Review

References (94)

1. Gougeon M-L, Montagnier L. 1993. Apoptosis in AIDS. Science 260:1269-70
2. Mountz JD, Wu J, Cheng J, Zhou T. 1994. Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum. 37:1415-20
3. Margolis RL, Chuang D-M, Post RM. 1994. Programmed cell death: implications for neuropsychiatric disorders. Biol. Psychiatry 35:946-56
4. Harrington EA, Fanidi A, Evan GI. 1994. Oncogenes and cell death. Curr. Opin. Genet. Dev. 4:120-29
5. Fisher DE. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-42
6. Wyllie AH, Kerr JF, Currie AR. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306
7. Tsujimoto Y, Croce CM. 1986. Analysis of the structure, transcription, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci USA 83:5214-18
8. Boise LH, Gonzalez-Garcia M, Postema CE, et al. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
9. Kozopas KM, Yang T, Buchan HL, et al. 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc. Natl. Acad. Sci. USA 90:3516-20
10. Lin EY, Orlofsky A, Berger MS, Prystowsky MB. 1993. Characterization of A1, a novel hematopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151:1979-88
11. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-19
12. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-91
13. Farrow SN, White JHM, Martinou I, et al. 1995. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731-33
14. Chittenden T, Harrington EA, O'Connor R, et al. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-36
15. Kiefer MC, Brauer MJ, Powers VC, et al. 1995. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736-39
16. Sato T, Hanada M, Bodrug S, et al. 1994. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 91:9238-42
17. Sedlak TW, Oltvai ZN, Yang E, et al. 1995. Multiple Bcl-2 family members demonstrate competing dimerizations with Bax. Proc. Natl Acad. Sci. USA 92:7834-38
18. Yin X-M, Oltvai ZN, Korsmeyer SJ. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heter-dimerization with Bax. Nature 369:321-23
19. Chittenden T, Flemington C, Houghton AB, et al. 1995. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:5589-96
20. Boyd JM, Gallo GJ, Elangovan B, et al. 1995. Bik, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11:1921-28
21. Hengartner MO, Ellis RE, Horvitz HR. 1992. C. elegans gene ced-9 protects from programmed cell death. Nature 356:494-99
22. Hengartner MO, Horvitz HR. 1994. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76:665-76
23. L, an inhibitor or programmed cell death. Nature. In press
24. Cramer WA, Heymann JB, Schendel SL, et al. 1995. Structure-function of the channel-forming colicins. Annu. Rev. Biophys. Biomol. Struct. 24:611-41
25. Yuan J, Shaham S, Ledoux S, et al. 1993. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75: 641-52
26. Shaham S, Horvitz HR. 1996. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 10:578-91
27. Henkart PA. 1996. ICE family proteases: mediators of all apoptotic cell death? Immunity 4:195-201
28. Duan H, Chinnaiyan AM, Hudson PL, et al. 1996. ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271:1621-25
29. Walker NP, Talanian RV, Brady KD, et al. 1995. Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 78: 343-52
30. Alnemri ES, Fernandes-Alnemri T, Litwack G. 1995. Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J. Biol. Chem. 270: 4312-17
31. Wang L, Miura M, Bergeron L, et al. 1994. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-50
32. Fernandes-Alnemri T, Litwack G, Alnemri ES. 1995. Mch2, a new member of the apoptotic CED-3/ICE cysteine protease gene family. Cancer Res. 55:2737-42
33. Li P, Allen H, Banerjee S, et al. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80: 401-11
34. Kiuda K, Lippke JA, Ku G, et al. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000-3
35. Nicholson DW, Ali A, Thornberry NA, et al. 1995. Identification and inhibition of the ICE/CED3 protease necessary for mammalian apoptosis. Nature 376:37-43
36. Tewari M, Quan LT, O'Rourke K, et al. 1995. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-9
37. Lazebnik YA, Kaufmann SH, Disnoyers S, et al. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-47
38. Wang Z-Q, Auer B, Stingl L, et al. 1995. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9:509-20
39. Eischen CM, Dick CJ, Leibson PJ. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947-54
40. Jacobson MD, Burne JF, Raff MC. 1994. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1899-910
41. Bazzoni F, Beutler B. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-25
42. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-12
43. Stanger BZ, Leder P, Lee T, et al. 1995. RIP: a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81:513-23
44. Hsu H, Xiong J, Goeddel DV. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504
45. Hsu H, Shu H-B, Pan M-G, Goeddel DV. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308
46. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-15
47. Muzio M, Chinnaiyan AM, Kischkel FC, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex (DISC). Cell 85: 817-27
48. Gulbins E, Bissonnette R, Mahboubi A, et al. 1995. Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2:341-51
49. Nerheij M, Bose R, Lin XH, et al. 1996. Requirement for ceramide-initiated SAPK/ JNK signaling in stress-induced apoptosis. Nature 380:75-79
50. Pronk GJ, Ramer K, Amiri P, Williams LT. 1996. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 271:808-10
51. Rothe M, Wong SC, Henzel WJ, Goeddel DV. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-92
52. Mosialos G, Birkenbach M, Yalamanchili R, et al. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-99
53. Chang G, Cleary AM, Ye Z, et al. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267: 1494-98
54. Hu HM, O'Rourke K, Boguski MS, Dixit VM. 1994. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269:30069-72
55. Sato T, Irie S, Reed JC. 1995. A novel member of the TRAF family of putative signal transducing proteins binds to the cytoplasmic domain of CD40. FEBS Lett. 358:113-18
56. Regnier CH, Tomasetto C, Moog-Lutz C, et al. 1995. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270:25715-21
57. Gedrich RW, Gilfillan MC, Duckett CS, et al. 1996. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271:12852-58
58. Rothe M, Sarma V, Dixit VM, Goeddel DV. 1995. TRAF2-mediated activation of NFκB by TNF receptor 2 and CD40. Science 269:1424-27
59. Boyd JM, Malstrom S, Subramanian T, et al. 1994. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79:341-51
60. Henderson S, Huen D, Rowe M, et al. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-83
61. Nielan JG, Lu Z, Afonzo L, et al. 1993. An African swine fever virus gene with similarity to the proto-oncogen bcl-2 and the Epstein-Barr virus gene BHRF1. J. Virol. 67:4391-94
62. Henderson S, Rowe M, Gregory C, et al. 1991. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-15
63. Ray CA, Black RA, Kronheim SR, et al. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69: 597-604
64. Bump NJ, Hackett M, Hugunin M, et al. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885-88
65. Roy N, Mahadevan MS, McLean M, et al. 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80:167-78
66. Rothe M, Pan M-G, Henzel WJ, et al. 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-52
67. Duckett CS, Nava VE, Gedrich RW, et al. 1996. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15: 2685-94
68. Liston P, Roy N, Tamai K, et al. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349-53
69. Uren AG, Pakusch M, Hawkins CJ, et al. 1996. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. USA 93:4974-78
70. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. 1992. Apoptotic cell death induced by c-myc is inhibited by Bcl-2. Nature 359:552-54
71. Lowe SW, Ruley HE, Jacks T, Housman DE. 1993. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-67
72. Symonds H, Krall L, Remington L, et al. 1994. P53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-11
73. Riley DJ, Lee EY-HP, Lee WH. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell. Biol. 10:1-29
74. Clarke A, Maandag E, van Roon M, et al. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-30
75. Lee EY-HP, Chang C-Y, Hu N, et al. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-94
76. Jacks T, Fazeli A, Schmitt E, et al. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300
77. Yamasaki L, Jacks T, Bronson R, et al. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-48
78. Field SJ, Tsai F-Y, Kuo F, et al. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-61
79. Harris CC, Hollstein M. 1993. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 329:1318-27
80. Lowe SW, Bodis S, McClatchey A, et al. 1994. P53 status and the efficacy of cancer therapy in vivo. Science 266:807-10
81. Miyashita T, Reed JC. 1992. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52:5407-11
82. Miyashita T, Reed JC. 1993. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151-57
83. Walton MI, Whysong D, O'Connor PM, et al. 1993. Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res. 53:1853-61
84. Fisher TC, Milner AE, Gregory CD, et al. 1993. Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res. 53: 3321-26
85. Dole M, Nunez G, Merchant AK, et al. 1994. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54:3253-59
86. L by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ. 6:363-70
87. L can confer a multidrug resistance phenotype. Blood 86:1903-10
88. Campos L, Rouault JP, Sabido O, et al. 1993. High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091-96
89. Olopade OI, Adeyanju MO, Safa AR, et al. 1996. Expression of the bcl-x gene in primary human breast cancer: association with high tumor grade and nodal metastases. ASCO Proc. 15:162 (Abstr.)
90. Webb A, Cunningham D, Cotter F, et al. 1996. Phase 1 bcl-2 antisense trial: preliminary results. Ann. Oncol. 7(3):32 (Abstr.)
91. Critchfield JM, Racke MK, Zuniga-Pflucker JC, et al. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139-43
92. Kornfield H, Cruikshank WW, Pyle SW, et al. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature 335:445-48
93. Banda NK, Bernier J, Kurahara DK, et al. 1992. Crosslinking CD4 by human immunodeficiency virus gp 120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-106
94. Li CJ, Friedman DJ, Wang C, et al. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-31